![Megan Sniecinski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Megan Sniecinski
Directeur des opérations chez
PRAXIS PRECISION MEDICINES, INC.
Fortune : 10 M $ au 31/05/2026
Profil
Megan Sniecinski is Chief Operating Officer at Praxis Precision Medicines, Inc. since 2026.
Formerly, Ms. Sniecinski was Chief Business Officer & Senior Vice President at BioCryst Pharmaceuticals, Inc. from 2019 to 2021, Senior VP-Business Operations & Program Management at PTC Therapeutics, Inc. from 2014 to 2019, and Chief of Staff & Director-Strategic Partnerships at Merck Vaccine Division from 2011 to 2014.
Education includes an undergraduate degree from the University of Virginia and an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/05/2026 | 28 664 ( 0,1% ) | 10 M $ | 31/05/2026 |
Postes actifs de Megan Sniecinski
| Sociétés | Poste | Début |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Directeur des opérations | 01/01/2026 |
Anciens postes connus de Megan Sniecinski
| Sociétés | Poste | Fin |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 09/08/2021 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2019 |
Merck Vaccine Division | Responsable des Ressources Humaines | 01/09/2014 |
Formation de Megan Sniecinski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Vaccine Division | |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
